Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Isofol Medical AB ( (SE:ISOFOL) ) just unveiled an announcement.
Isofol Medical AB has announced a change in the number of shares and votes following a rights issue, overallotment issue, and set-off issue. This adjustment, registered with the Swedish Companies Registration Office, has increased the total number of shares and votes to 281,107,224, reflecting the company’s strategic financial maneuvers to support its operations and growth.
More about Isofol Medical AB
Isofol Medical AB is a research-based biotechnology company focused on improving treatments for severe forms of cancer. The company is developing arfolitixorin, a drug candidate aimed at enhancing the efficacy of standard treatments for solid tumors, particularly in colorectal cancer, which is the third most common cancer globally. Isofol Medical AB is listed on Nasdaq Stockholm.
Average Trading Volume: 1,384,492
Technical Sentiment Signal: Sell
Current Market Cap: SEK263.1M
For an in-depth examination of ISOFOL stock, go to TipRanks’ Overview page.